Sergey N. Mikhailov

Prof. Sergey N. Mikhailov

orcid

Research Focus & Metrics

Academic Career Length

54Years (1973-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2009 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JBJesper B. Bramsen
Jesper B. Bramsen
MLMaria B. Laursen
Maria B. Laursen
ANAnne F. Nielsen
Anne F. Nielsen
THThomas Birkballe Hansen
Thomas Birkballe Hansen
CBClaus Bus
Claus Bus
JKJørgen Kjems
Jørgen Kjems
The use of chemically synthesized short interfering RNAs (siRNAs) is currently the method of choice to manipulate gene expression in mammalian cell culture, yet improvements of siRNA design is expectably required for successful application in vivo. Several studies have aimed at improving siRNA performance through the introduction of chemical modifications but a direct comparison of these results is difficult. We have directly compared the effect of 21 types of chemical modifications on siRNA activity and toxicity in a total of 2160 siRNA duplexes. We demonstrate that siRNA activity is primarily enhanced by favouring the incorporation of the intended antisense strand during RNA-induced silencing complex (RISC) loading by modulation of siRNA thermodynamic asymmetry and engineering of siRNA 3′-overhangs. Collectively, our results provide unique insights into the tolerance for chemical modifications and provide a simple guide to successful chemical modification of siRNAs with improved activity, stability and low toxicity.

26 May 2009 in Russian Journal of Bioorganic Chemistry
Verified
Journal Article
Closed access
PDF file
Nataliya R. KildeevaNataliya R. Kildeeva
Nataliya R. Kildeeva
PPP. A. Perminov
P. A. Perminov
LVL. V. Vladimirov
L. V. Vladimirov
VNValentin Novikov
Valentin Novikov
SMSergey N. Mikhailov
Sergey N. Mikhailov
The regularities of the reaction of aminopolysaccharide chitosan with glutaraldehyde (GA) have been considered. The equilibrium forms of GA in water have been thoroughly studied by NMR spectroscopy....

1 March 2002 in Nucleic Acids Research
Verified
Journal Article
Closed access
PDF file
SMSergey N. Mikhailov
Sergey N. Mikhailov
JRJef Rozenski
Jef Rozenski
EEEkaterina V. Efimtseva
Ekaterina V. Efimtseva
RBRoger Busson
Roger Busson
AAArthur Van Aerschot
Arthur Van Aerschot
PHPiet Herdewijn
Piet Herdewijn
The base moiety of 1-N-methyladenosine can be protected with a chloroacetyl group for incorporation of this modified nucleoside into DNA and RNA. Carefully controlled anhydrous conditions are needed for deprotection of the oligonucleotides.

1 July 2016 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
MDMikhail S. Drenichev
Mikhail S. Drenichev
VOVladimir E. Oslovsky
Vladimir E. Oslovsky
SMSergey N. Mikhailov
Sergey N. Mikhailov
Cytokinin nucleosides exhibit antitumor, antiviral, antiprotozoal, blood pressure reducing, anti-inflammatory, and antipsychotic activity. These compounds also influence platelet aggregation and exhibit some other biological activities. Cytokinins are N6-substituted adenines and represent an important group of phytohormones with diverse biochemical functions in plants, stimulating cell division and plant growth. The main structural feature of cytokinin nucleosides is the presence of a hydrophobic hydrocarbon moiety at the N6-position of adenosine. This moiety is responsible for a difference in physicochemical and biological properties as compared to adenosine. 1-N-Tuberculosinyladenosine and N6-tuberculosinyladenosine are specifically produced by Mycobacterium tuberculosis as components of the plasmatic membrane, thus making them attractive targets for clinical test development. Structurally related compounds were found in marine organisms. It has been shown also that tRNA contains N6-isoprenyladenosine and some other related compounds. This review summarizes the structural features, biological activity, and the synthesis of cytokinin nucleosides and some of their closely related derivatives such as cytokinins and terpene derivatives of adenine.

1 February 2002 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
GRGregory G. Reinholz
Gregory G. Reinholz
BGBarbara Getz
Barbara Getz
ESEmily S. Sanders
Emily S. Sanders
MKMarat Ya. Karpeisky
Marat Ya. Karpeisky
NPNelly Sh. Padyukova
Nelly Sh. Padyukova
TSThomas C. Spelsberg
Thomas C. Spelsberg

1 March 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MDMikhail S. Drenichev
Mikhail S. Drenichev
VOVladimir E. Oslovsky
Vladimir E. Oslovsky
LSLiang Sun
Liang Sun
ATAloys Tijsma
Aloys Tijsma
NKNikolay N. Kurochkin
Nikolay N. Kurochkin
SMSergey N. Mikhailov
Sergey N. Mikhailov